uniQure (QURE) EBT Margin (2016 - 2026)

uniQure (QURE) recorded quarterly EBT Margin of 1489.25% in Q1 2026, down 274.04% quarter-over-quarter from 398.15% in Q4 2025, and up 126385.0% on a YoY basis from N/an in Q1 2025.

uniQure (QURE) EBT Margin (2016 - 2026) Analysis & Trends

uniQure's EBT Margin history runs 11 years deep, the most recent figure standing at 1489.25% for Q1 2026.

  • In Q1 2026, EBT Margin rose 126385.0% year-over-year to 1489.25%; the TTM figure through Mar 2026 stood at 1019.25% (down 6172.0% YoY), while the FY2025 annual figure was 1084.03%, down 29030.0% from the prior year.
  • EBT Margin was 1489.25% for Q1 2026 at uniQure, down from 398.15% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 6.42% in Q4 2022 to a low of 7923.34% in Q2 2022.
  • Historically, EBT Margin has averaged 2179.98% across 5 years, with a median of 1489.25% in 2026.
  • Biggest YoY gain for EBT Margin was 646721 bps in 2022; the steepest drop was 801016 bps in 2022.
  • A 5-year view of EBT Margin shows it stood at 6.42% in 2022, then sank by 16431 bps to 1049.07% in 2023, then climbed by 8 bps to 967.8% in 2024, then surged by 59 bps to 398.15% in 2025, then slumped by 274 bps to 1489.25% in 2026.
  • The last three EBT Margin figures came in at 1489.25% (Q1 2026), 398.15% (Q4 2025), and 1942.8% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 uniQure 2.88 Bn 2.88 Bn 3.34 Mn -1,489.25%

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,489.25%
Dec 31, 2025 -398.15%
Sep 30, 2025 -1,942.80%
Jun 30, 2025 -708.74%
Mar 31, 2025 -2,753.10%
Dec 31, 2024 -967.80%
Sep 30, 2024 -1,941.80%
Jun 30, 2024 -497.49%
Mar 31, 2024 -765.61%
Dec 31, 2023 -1,049.07%
Sep 30, 2023 -6,371.00%
Jun 30, 2023 -2,820.44%
Mar 31, 2023 -1,472.94%
Dec 31, 2022 6.42%
Sep 30, 2022 -3,325.47%
Jun 30, 2022 -7,923.34%
Mar 31, 2022 -2,639.17%
Dec 31, 2021 13.63%
Sep 30, 2021 -1,832.18%
Jun 30, 2021 86.82%